This program is designed for individuals in Miami who approach metabolic health with precision and long-term intent
Our team cares about the fact that you are an individual with your input, particular needs, and goals, and your body is unique to you
Notably, the 2024 FDA approval of Wegovy for cardiovascular risk reduction in adults with established cardiovascular disease and obesity/overweight (based on the SELECT trial) provides additional evidence of cardiometabolic benefits beyond glycemic control
Tirzepatide amplifies these natural pathways: GLP-1 receptor activation increases insulin secretion in response to meals, suppresses glucagon release (which lowers blood sugar), slows gastric emptying, and reduces appetite through hypothalamic signaling GIP receptor activation enhances insulin sensitivity, may improve fat metabolism, and appears to work synergistically with GLP-1 to produce greater appetite suppression and weight loss than either pathway alone Research published in Cell Metabolism suggests that GIP receptor activation may also influence adipose tissue function and energy expenditure, contributing to tirzepatides superior weight loss outcomes compared to GLP-1-only medications (Samms et al., 2020)
This is particularly relevant for conditions like gum recession , where the gum line pulls away from the teeth, exposing the root surface
Quality Assurance & Manufacturing Standards Each vial of BPC-157 Wolverine peptide undergoes strict quality control procedures to ensure research integrity